Eikan Mishima

5.5k total citations · 2 hit papers
63 papers, 2.2k citations indexed

About

Eikan Mishima is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, Eikan Mishima has authored 63 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 24 papers in Pulmonary and Respiratory Medicine and 14 papers in Nephrology. Recurrent topics in Eikan Mishima's work include RNA modifications and cancer (13 papers), Ferroptosis and cancer prognosis (12 papers) and Renal and Vascular Pathologies (10 papers). Eikan Mishima is often cited by papers focused on RNA modifications and cancer (13 papers), Ferroptosis and cancer prognosis (12 papers) and Renal and Vascular Pathologies (10 papers). Eikan Mishima collaborates with scholars based in Japan, Germany and United States. Eikan Mishima's co-authors include Takaaki Abe, Marcus Conrad, Sadayoshi Ito, Takehiro Suzuki, Yasutoshi Akiyama, Kôichi Kikuchi, Chitose Suzuki, Bettina Proneth, Tomoyoshi Soga and Yoichi Takeuchi and has published in prestigious journals such as Nature, Cell and Nature Reviews Molecular Cell Biology.

In The Last Decade

Eikan Mishima

60 papers receiving 2.2k citations

Hit Papers

Phase separation of FSP1 promotes ferroptosis 2023 2026 2024 2025 2023 2025 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Phase separation of FSP1 promotes ferroptosis
    2023 228 citations Toshitaka Nakamura, André Mourão et al. Nature profile →
  2. Recommendations for robust and reproducible research on ferroptosis
    2025 21 citations Eikan Mishima, Toshitaka Nakamura et al. Nature Reviews Molecular Cell Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eikan Mishima Japan 24 1.2k 636 500 430 312 63 2.2k
Ya‐Long Feng China 23 1.5k 1.2× 452 0.7× 229 0.5× 579 1.3× 225 0.7× 33 3.0k
Subhashini Bolisetty United States 31 1.5k 1.2× 537 0.8× 329 0.7× 394 0.9× 212 0.7× 42 2.8k
Adrián M. Ramos Spain 30 1.3k 1.0× 328 0.5× 335 0.7× 870 2.0× 189 0.6× 62 3.0k
Qingqing Wu China 30 1.7k 1.3× 481 0.8× 509 1.0× 123 0.3× 184 0.6× 81 3.0k
Sandra Rayego‐Mateos Spain 31 1.3k 1.1× 306 0.5× 252 0.5× 951 2.2× 187 0.6× 72 3.1k
Gloria Álvarez‐Llamas Spain 29 1.2k 1.0× 181 0.3× 305 0.6× 354 0.8× 349 1.1× 96 2.4k
Liyu He China 27 1.3k 1.0× 239 0.4× 230 0.5× 1.2k 2.8× 234 0.8× 93 3.1k

Countries citing papers authored by Eikan Mishima

Since Specialization
Citations

This map shows the geographic impact of Eikan Mishima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eikan Mishima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eikan Mishima more than expected).

Fields of papers citing papers by Eikan Mishima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eikan Mishima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eikan Mishima. The network helps show where Eikan Mishima may publish in the future.

Co-authorship network of co-authors of Eikan Mishima

This figure shows the co-authorship network connecting the top 25 collaborators of Eikan Mishima. A scholar is included among the top collaborators of Eikan Mishima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eikan Mishima. Eikan Mishima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iwamoto, Yukihide, Akiyo Sekimoto, Takashi Toyama, et al.. (2025). Lactoferrin attenuates renal fibrosis and uremic sarcopenia in a mouse model of adenine-induced chronic kidney disease. The Journal of Nutritional Biochemistry. 146. 110039–110039.
2.
Mishima, Eikan, Toshitaka Nakamura, Sebastian Doll, et al.. (2025). Recommendations for robust and reproducible research on ferroptosis. Nature Reviews Molecular Cell Biology. 26(8). 615–630. 21 indexed citations breakdown →
3.
Yang, Jia‐Shu, Andrew Morris, Koki Kamizaki, et al.. (2025). ALDH7A1 protects against ferroptosis by generating membrane NADH and regulating FSP1. Cell. 188(10). 2569–2585.e20. 8 indexed citations
4.
Toyama, Tadashi, Eikan Mishima, Kei Ishida, et al.. (2024). Impact of selenium content in fetal bovine serum on ferroptosis susceptibility and selenoprotein expression in cultured cells. The Journal of Toxicological Sciences. 49(12). 555–563. 5 indexed citations
5.
Sekimoto, Akiyo, Takafumi Toyohara, Daisuke Saigusa, et al.. (2024). Impacts of low birthweight on kidney development and intergenerational growth of the offspring. iScience. 27(11). 111159–111159.
6.
Mishima, Eikan. (2024). Targeting ferroptosis for treating kidney disease. Clinical and Experimental Nephrology. 28(9). 866–873. 2 indexed citations
7.
Nakamura, Toshitaka, André Mourão, Jan Borggräfe, et al.. (2023). Phase separation of FSP1 promotes ferroptosis. Nature. 619(7969). 371–377. 228 indexed citations breakdown →
8.
Mishima, Eikan, Adam Wahida, Tobias Seibt, & Marcus Conrad. (2023). Diverse biological functions of vitamin K: from coagulation to ferroptosis. Nature Metabolism. 5(6). 924–932. 42 indexed citations
9.
Watanabe, Kimio, Emiko Sato, Eikan Mishima, et al.. (2023). Changes in Metabolomic Profiles Induced by Switching from an Erythropoiesis-Stimulating Agent to a Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor in Hemodialysis Patients: A Pilot Study. International Journal of Molecular Sciences. 24(16). 12752–12752.
10.
Watanabe, Kimio, Emiko Sato, Eikan Mishima, et al.. (2021). Effect of uremic toxins on hippocampal cell damage: analysis in vitro and in rat model of chronic kidney disease. Heliyon. 7(2). e06221–e06221. 21 indexed citations
11.
Zheng, Jiashuo, Mami Sato, Eikan Mishima, et al.. (2021). Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines. Cell Death and Disease. 12(7). 698–698. 144 indexed citations
12.
Mishima, Eikan, Takehiro Suzuki, Takafumi Toyohara, et al.. (2020). Concurrent analogous organ damage in the brain, eyes, and kidneys in malignant hypertension: reversible encephalopathy, serous retinal detachment, and proteinuria. Hypertension Research. 44(1). 88–97. 12 indexed citations
13.
Mishima, Eikan, Yoshisuke Haruna, & Hisatomi Arima. (2019). Renin-angiotensin system inhibitors in hypertensive adults with non-diabetic CKD with or without proteinuria: a systematic review and meta-analysis of randomized trials. Hypertension Research. 42(4). 469–482. 30 indexed citations
14.
Mishima, Eikan & Takaaki Abe. (2018). Immuno-Northern Blotting: Detection of Modified RNA Using Gel Separation and Antibodies to Modified Nucleosides. Methods in molecular biology. 1870. 179–187. 10 indexed citations
15.
Mishima, Eikan, Takehiro Suzuki, Junichiro Hashimoto, Takaaki Abe, & Sadayoshi Ito. (2017). ‘Lead pipe’-like stiff aorta with grossly widened pulse pressure in burned-out Takayasu arteritis. European Heart Journal - Cardiovascular Imaging. 18(7). 819–819. 2 indexed citations
16.
Mishima, Eikan, Takayasu Mori, Eisei Sohara, et al.. (2017). Inherited, not acquired, Gitelman syndrome in a patient with Sjögren’s syndrome: importance of genetic testing to distinguish the two forms. CEN Case Reports. 6(2). 180–184. 11 indexed citations
17.
Mishima, Eikan, Shinji Fukuda, Hisato Shima, et al.. (2014). Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD. Journal of the American Society of Nephrology. 26(8). 1787–1794. 152 indexed citations
18.
Akiyama, Yasutoshi, Kôichi Kikuchi, Daisuke Saigusa, et al.. (2013). Indoxyl Sulfate Down-Regulates SLCO4C1 Transporter through Up-Regulation of GATA3. PLoS ONE. 8(7). e66518–e66518. 21 indexed citations
19.
Toyohara, Takafumi, Takehiro Suzuki, Yasutoshi Akiyama, et al.. (2011). Metabolomic profiling of the autosomal dominant polycystic kidney disease rat model. Clinical and Experimental Nephrology. 15(5). 676–687. 21 indexed citations
20.
Toyohara, Takafumi, Yasutoshi Akiyama, Takehiro Suzuki, et al.. (2010). Metabolomic profiling of uremic solutes in CKD patients. Hypertension Research. 33(9). 944–952. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ya‐Long Feng Breakdown of academic impact, for papers by Subhashini Bolisetty Breakdown of academic impact, for papers by Adrián M. Ramos Breakdown of academic impact, for papers by Qingqing Wu Breakdown of academic impact, for papers by Sandra Rayego‐Mateos Breakdown of academic impact, for papers by Gloria Álvarez‐Llamas Breakdown of academic impact, for papers by Liyu He
Rankless by CCL
2026